Pilot study of egfr inhibition with erlotinib in cirrhosis to inhibit fibrogenesis and prevent hepatocellular carcinoma
Ended Awarded Last action
- Contract number
- HHSN26100007
- Awardee
-
Mayo Clinic UEI Y2K4F9RPRRG7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $536,992
Award facts
- Opportunity
-
- N01CN0501469 Solicitation number
- Contract value 100% obligated
- $536,992.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Rochester, MN 55905, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$52,944 | |
| Funding Only Action | -$5,557 | |
| Supplemental Agreement for work within scope | $0 | |
| Change Order | -$38,881 | |
| Exercise an Option | $92,891 | |
| Supplemental Agreement for work within scope | $24,352 | |
| Exercise an Option | $45,455 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $471,677 |
About this award
The National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a $536,992.49 delivery order contract to Mayo Clinic to conduct a pilot study on the use of the EGFR inhibitor erlotinib to inhibit fibrogenesis and prevent hepatocellular carcinoma in patients with cirrhosis. This contract is part of NCI's Cancer Prevention Agent Development Program, which supports early-phase clinical research. Mayo Clinic is a non-profit academic medical center that frequently provides research and development services to federal agencies through prime contracts and subcontracts. For this study, Mayo Clinic is partnering with Massachusetts General Hospital, Icahn School of Medicine at Mount Sinai, and Case Western Reserve University as subcontractors. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract HHSN26100007?
HHSN26100007 was awarded to Mayo Clinic by National Cancer Institute (National Institutes of Health) on September 5, 2014.
How much is contract HHSN26100007 worth?
The government has obligated $536,992 on HHSN26100007.
Is contract HHSN26100007 an order under another contract?
Yes. HHSN26100007 is a delivery order under HHSN261201200042I, an indefinite delivery contract.
Was contract HHSN26100007 competed?
The extent of competition for HHSN26100007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award